NCT03529292View on ClinicalTrials.gov

Pilot Study to Evaluate the Safety and the Efficacy of the Matrix and Cells Obtained by the AmeaCell® Device and Intended for the Filling of Wrinkles on the Face.

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 9, 2018

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Skin Aging
Interventions
DEVICE

AmeaCell

Lipoaspirate obtained from liposuction is treated by the AmeaCell® device in order to obtain Matrix and Cells which contains cellular phase and matrix phase. The Matrix ancd Cells are injected in the same patient as facial wrinkles filler.

Trial Locations (1)

Unknown

Hôpital Erasme, Brussels

All Listed Sponsors
lead

Symbioken

INDUSTRY

NCT03529292 - Pilot Study to Evaluate the Safety and the Efficacy of the Matrix and Cells Obtained by the AmeaCell® Device and Intended for the Filling of Wrinkles on the Face. | Biotech Hunter | Biotech Hunter